Vera Glossary

With Breast Cancer Awareness Month well under way, we are taking this time to share our “Vera glossary”. You may already be familiar with our technology – we believe our Koning Vera Breast CT will dramatically improve the way clinicians visualize and evaluate breast tissue. We want to optimize early disease detection, diagnostic intervention and treatment to improve survival rates for millions of patients with the power and versatility of the Koning Vera Breast CT. 

Terms to understand about Vera: 

Computed Tomography Technology

Computed tomography (CT) imaging provides a form of imaging known as cross-sectional imaging. The origin of the word "tomography" is from the Greek word "tomos" meaning "slice" and "graphe" meaning "drawing." A CT imaging system produces cross-sectional images or "slices" of anatomy, like the slices in a loaf of bread.

3D-Guided Biopsy

The Koning Vera Breast CT offers 3D-guided biopsy measurements guided by X-ray, with the average biopsy taking just 15 minutes. The two most important factors are targeting accuracy by utilizing isotropic 3D-targeting, and reducing the number of images so that there is a lower radiation exposure level.

Calcification Detection

Our system offers a revolutionary diagnostic technique for breast imaging and CT-guided interventions, and can significantly improve the detection of breast masses and microcalcifications thanks to its high resolution and potential use for reconstruction.

Density Distribution Management

Approximately 50% of women have dense breast tissue and are at higher risk of developing breast cancer. Our device uses computed tomography to maximize accuracy for all women, regardless of the type of breast tissue, overcoming the limitations of current imaging for dense breast tissue and overlapping structures. 

No Compression

The Koning Vera Breast CT overcomes the painful compression women often experience during mammograms. During a 2022 HealthyWomen survey, 1 in 6 women reported that discomfort has deterred them from getting a mammogram as recommended. By eliminating compression and developing new technologies that are just as effective at imaging dense breasts, we get closer to a reality of far fewer false negatives. Most importantly, by developing technology that keeps women healthy without trade-offs, we can equalize early detection for the first time.